José Antonio Garrido (ICREA @ ICN2) and Carolina Aguilar are the entrepreneurs of the biotech InBrain Neuroelectronics, a spin-off company established in 2019 and based in Barcelona. The investment was led by Imec.xpand, Belgian venture capital fund specialised in semiconductors and nanotechnology.

InBrain technology was successfully used for the first time ever in a human patient undergoing surgical resection of a gliomal tumour. InBrain sensors were able to distinguish malingnat cells from healthy tissue to guide the scalpel of the resection with unprecedented precision.

See below a couple of press releases, and click here to go to ICN2 website and find out more about the science behind this breakthrough.
Biocat
The New Barcelona Post

OTHER NEWS

News Awards

Premis Ciutat de Barcelona – 2024

The Ciutat de Barcelona Awards, granted by the Barcelona City Council, aim to recognise artistic and cultural creation linked to…

News Awards

Premios Rei Jaume I – 2024

Three ICREA Research Professors received the Premio Rei Jaume I in the 37th edition of this award. Congratulation to: ·…